Red Light Therapy for Blood Clots & DVT

Blood clots — including deep vein thrombosis (DVT), pulmonary embolism (PE), and arterial thrombosis — are serious, potentially life-threatening medical conditions. They require immediate medical treatment, typically anticoagulation therapy, and in some cases surgical or interventional procedures.

Red light therapy is sometimes discussed in the context of blood clots, circulation, and vascular health. This page examines the evidence honestly — and begins with a clear safety statement.

Safety first: a critical warning

Red light therapy is not a treatment for blood clots. If you suspect you have a DVT (swelling, pain, warmth, or redness in a limb — usually the calf or thigh) or PE (sudden shortness of breath, chest pain, coughing blood), seek emergency medical attention immediately.

Blood clots can be fatal. A DVT can break loose and travel to the lungs (pulmonary embolism), which kills approximately 25,000 people per year in the UK. This is not a condition amenable to home treatment with light therapy.

Do not apply red light therapy to an area where you suspect an active blood clot. The theoretical concern is that vasodilation, improved blood flow, or tissue heating could potentially dislodge a clot, leading to embolism. This risk is speculative but cannot be excluded, and given the stakes (fatal PE), caution is warranted.

What the evidence actually shows

Direct evidence for PBM and blood clots

There are no published clinical trials examining red light therapy as a treatment for blood clots. Zero RCTs, zero controlled studies, zero case series in peer-reviewed journals.

This is not a “limited evidence” situation. It is a “no evidence” situation.

PBM and circulation

Where PBM does have some relevance is in its effects on circulation and vascular function — which are related to, but distinct from, blood clot treatment.

Nitric oxide (NO) release: PBM at 630–850nm has been shown to release NO from intracellular stores (particularly from cytochrome c oxidase and haemoglobin). NO is a potent vasodilator — it relaxes smooth muscle in blood vessel walls, increasing local blood flow (Hamblin, 2017).

Improved microcirculation: Several studies have demonstrated that PBM increases capillary blood flow and microcirculatory function. Maegawa et al. (2000) showed that 830nm LLLT increased blood flow velocity in arterioles and venules in a rat mesentery model. Human studies have confirmed improved peripheral microcirculation following PBM, measured by laser Doppler flowmetry.

Endothelial function: PBM may improve endothelial cell function, which plays a role in maintaining vascular health and preventing inappropriate clot formation. However, this has been studied primarily in vitro and in animal models.

PBM and platelet function

A small number of studies have examined PBM effects on platelets (the blood cells responsible for clot formation):

Moreira et al. (2019) examined the effects of PBM on platelet aggregation in vitro and found that specific doses of 660nm light could influence platelet activation. The results were variable — some parameters increased aggregation, others decreased it.

Brill et al. (2000) found that HeNe laser irradiation (632.8nm) of blood samples in vitro influenced platelet aggregation and fibrinolysis, but the clinical significance of these in vitro findings is entirely unclear.

The bottom line on platelet research: PBM can influence platelet behaviour in a test tube, but whether this translates to any clinically meaningful effect on clot formation or resolution in a living person is unknown.

Conditions where PBM and vascular health intersect

Post-thrombotic syndrome

After a DVT has been treated (with anticoagulation), some patients develop post-thrombotic syndrome (PTS) — chronic leg swelling, pain, skin changes, and sometimes venous ulcers. PTS is driven by venous damage from the original clot and chronic venous insufficiency.

PBM has some evidence for:

Venous leg ulcer healing — A Cochrane review (Flemming and Cullum, 2001) found limited evidence that LLLT may improve venous ulcer healing, though the quality of included studies was poor
Improved microcirculation — Which could theoretically benefit the chronic venous insufficiency underlying PTS
Anti-inflammatory effects — Which could reduce the chronic inflammation in PTS-affected legs

However, no study has specifically examined PBM for post-thrombotic syndrome as a defined condition.

Peripheral arterial disease (PAD)

PAD involves atherosclerotic narrowing of limb arteries, reducing blood flow. PBM’s vasodilatory effects could theoretically improve symptoms (claudication, poor wound healing), but clinical evidence is minimal.

Schindl et al. (2002) reported improved wound healing and microcirculation in a small study of patients with diabetic and arterial foot ulcers treated with PBM. But this is a wound healing study, not a PAD treatment study.

Varicose veins and chronic venous insufficiency

PBM is sometimes marketed for varicose veins. There is no evidence that PBM treats varicose veins (which are structural abnormalities requiring sclerotherapy, ablation, or surgery). PBM may provide modest symptomatic relief (reduced heaviness, improved skin trophism) through improved microcirculation, but it will not eliminate varicose veins.

Why the claims persist

Despite the absence of evidence, “red light therapy for blood clots” remains a popular search query. This likely reflects:

Conflation with circulation — PBM does improve microcirculation, and some people extrapolate this to mean it can treat or prevent blood clots. Improved capillary flow and dissolving a venous thrombus are entirely different things.
Misunderstanding of “blood flow” — In PBM marketing, “improved blood flow” is a common claim. People with clot concerns may assume that improved blood flow means clot prevention or treatment. This is not how blood clots work.
Alternative medicine communities — Some naturopathic and functional medicine practitioners recommend PBM for vascular health broadly, and patients with clotting concerns may encounter these recommendations.

A responsible approach

If you have an active blood clot

Seek immediate medical attention
Do not apply PBM to the affected area
Follow your doctor’s anticoagulation protocol
PBM has no role here

If you are on anticoagulation and want to use PBM for other reasons

PBM is generally safe alongside anticoagulant medications
Avoid applying PBM to areas with active bruising or haematoma, as improved blood flow could theoretically worsen bleeding
Inform your healthcare team about any complementary therapies you use

If you want to support general vascular health

PBM may modestly improve microcirculation — this is supported by evidence
Apply to the limbs (calves, thighs, forearms) using 660nm or 830nm, 10–20 J/cm², 3–5 times per week
This is a general wellness application, not a medical treatment
The fundamentals matter more: regular exercise, maintaining a healthy weight, avoiding prolonged immobility, staying hydrated, not smoking

If you have chronic venous insufficiency or post-thrombotic syndrome

PBM may offer modest symptomatic benefit through improved microcirculation and anti-inflammatory effects
Use alongside, not instead of, compression stockings and medical management
660nm or 830nm, applied to the affected limb, 10–20 J/cm², daily or every other day

The bottom line

Red light therapy has no role in treating blood clots. None. The evidence is non-existent, and the safety concerns (potential clot dislodgement, delayed medical treatment) are serious.

PBM does have modest evidence for improving microcirculation and may support general vascular health, venous ulcer healing, and post-thrombotic symptom management. These are secondary, supportive applications — not replacements for medical treatment.

If you have a blood clot, see a doctor. If you are on anticoagulants, keep taking them. No amount of red light will dissolve a thrombus or replace warfarin. Be deeply wary of anyone suggesting otherwise.